Abstract
OBJECTIVES: This study analyzed prostate cancer treatment rates by age and clinical stage and contrasted these with rates by most accurate stage. METHODS: We determined surgery and radiation rates by most accurate and clinical stage by using 1996 Surveillance, Epidemiology, and End Results data. RESULTS: Treatment rates by clinical stage vs best stage differ significantly. For example, surgery rates for stages B, C, and D are 37%, 78%, and 13% by most accurate stage but 33%, 6%, and 1% by clinical stage. Treatment patterns by clinical stage vary substantially by age. CONCLUSIONS: Treatment patterns should be described by clinical stage rather than most accurate stage, and they vary by age.
Full Text
The Full Text of this article is available as a PDF (77.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Harlan L., Brawley O., Pommerenke F., Wali P., Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol. 1995 Jan;13(1):93–100. doi: 10.1200/JCO.1995.13.1.93. [DOI] [PubMed] [Google Scholar]
- Klabunde C. N., Potosky A. L., Harlan L. C., Kramer B. S. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998 Sep;36(9):1337–1348. doi: 10.1097/00005650-199809000-00006. [DOI] [PubMed] [Google Scholar]
- Lu-Yao G. L., Greenberg E. R. Changes in prostate cancer incidence and treatment in USA. Lancet. 1994 Jan 29;343(8892):251–254. doi: 10.1016/s0140-6736(94)91109-6. [DOI] [PubMed] [Google Scholar]
- Lu-Yao G. L., McLerran D., Wasson J., Wennberg J. E. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA. 1993 May 26;269(20):2633–2636. doi: 10.1001/jama.269.20.2633. [DOI] [PubMed] [Google Scholar]
- Mettlin C. J., Murphy G. P., Cunningham M. P., Menck H. R. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer. 1997 Oct 1;80(7):1261–1266. [PubMed] [Google Scholar]
- Mettlin C. J., Murphy G. P., Ho R., Menck H. R. The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer. 1996 May 15;77(10):2162–2166. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2162::AID-CNCR30>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
- Mettlin C. J., Murphy G. P., Rosenthal D. S., Menck H. R. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998 Oct 15;83(8):1679–1684. doi: 10.1002/(sici)1097-0142(19981015)83:8<1679::aid-cncr24>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Mettlin C. J., Murphy G. The National Cancer Data Base report on prostate cancer. Cancer. 1994 Sep 1;74(5):1640–1648. doi: 10.1002/1097-0142(19940901)74:5<1640::aid-cncr2820740525>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Partin A. W., Kattan M. W., Subong E. N., Walsh P. C., Wojno K. J., Oesterling J. E., Scardino P. T., Pearson J. D. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997 May 14;277(18):1445–1451. [PubMed] [Google Scholar]
- Polednak A. P. Geographic variation in the treatment of prostate cancer in Connecticut. Int J Technol Assess Health Care. 1993 Spring;9(2):304–310. doi: 10.1017/s0266462300004517. [DOI] [PubMed] [Google Scholar]
- Severson R. K., Montie J. E., Porter A. T., Demers R. Y. Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst. 1995 Apr 5;87(7):532–534. doi: 10.1093/jnci/87.7.532. [DOI] [PubMed] [Google Scholar]